{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T09:32:23Z","timestamp":1792575143924,"version":"4.5.0"},"reference-count":216,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100005247","name":"University of British Columbia","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005247","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010443","name":"RACP Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010443","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001316","name":"Abbott Laboratories","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001316","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004374","name":"Medtronic","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004374","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100019688","name":"Department of Medicine, Georgetown University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100019688","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["RN380020\u2013406814"],"award-info":[{"award-number":["RN380020\u2013406814"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JACC: Clinical Electrophysiology"],"published-print":{"date-parts":[[2022,3]]},"DOI":"10.1016\/j.jacep.2021.12.001","type":"journal-article","created":{"date-parts":[[2022,3,21]],"date-time":"2022-03-21T14:58:18Z","timestamp":1647874698000},"page":"386-405","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":131,"title":["Brugada Syndrome"],"prefix":"10.1016","volume":"8","author":[{"given":"Andrew D.","family":"Krahn","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elijah R.","family":"Behr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Hamilton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent","family":"Probst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zachary","family":"Laksman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui-Chen","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jacep.2021.12.001_bib1","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1016\/0735-1097(92)90253-J","article-title":"Right bundle branch block, persistent ST segment elevation and sudden cardiac death: a distinct clinical and electrocardiographic syndrome. A multicenter report","volume":"20","author":"Brugada","year":"1992","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacep.2021.12.001_bib2","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1161\/CIRCEP.111.964577","article-title":"Brugada syndrome","volume":"5","author":"Mizusawa","year":"2012","journal-title":"Circ Arrhythmia Electrophysiol"},{"key":"10.1016\/j.jacep.2021.12.001_bib3","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1016\/j.jacc.2018.06.037","article-title":"Present status of Brugada syndrome: JACC State-of-the-Art Review","volume":"72","author":"Brugada","year":"2018","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacep.2021.12.001_bib4","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1097\/00000441-195322650-00011","article-title":"Electrocardiographic pattern simulating acute myocardial injury","volume":"226","author":"Osher","year":"1953","journal-title":"Am J Med Sci"},{"key":"10.1016\/j.jacep.2021.12.001_bib5","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/S0002-9343(00)00714-2","article-title":"Molecular biology of sodium channels and their role in cardiac arrhythmias","volume":"110","author":"Grant","year":"2001","journal-title":"Am J Med"},{"key":"10.1016\/j.jacep.2021.12.001_bib6","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.yjmcc.2006.12.005","article-title":"The promiscuous nature of the cardiac sodium current","volume":"42","author":"Haufe","year":"2007","journal-title":"J\u00a0Mol Cell Cardiol"},{"key":"10.1016\/j.jacep.2021.12.001_bib7","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1007\/s00424-009-0761-0","article-title":"Cardiac sodium channelopathies","volume":"460","author":"Amin","year":"2010","journal-title":"Pflugers Archiv"},{"key":"10.1016\/j.jacep.2021.12.001_bib8","doi-asserted-by":"crossref","first-page":"7093","DOI":"10.1021\/jm501981g","article-title":"Voltage-gated sodium channels: structure, function, pharmacology, and clinical indications","volume":"58","author":"de Lera Ruiz","year":"2015","journal-title":"J\u00a0Med Chem"},{"key":"10.1016\/j.jacep.2021.12.001_bib9","first-page":"569","article-title":"Clinical spectrum of SCN5A mutations: long QT syndrome, Brugada syndrome, and cardiomyopathy","volume":"4","author":"Wilde","year":"2018","journal-title":"J\u00a0Am Coll Cardiol EP"},{"key":"10.1016\/j.jacep.2021.12.001_bib10","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1212\/01.WNL.0000042093.96309.5A","article-title":"Paramyotonia congenita with an SCN4A mutation affecting cardiac repolarization","volume":"60","author":"P\u00e9r\u00e9on","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.jacep.2021.12.001_bib11","doi-asserted-by":"crossref","first-page":"1844","DOI":"10.1172\/JCI73140","article-title":"A\u00a0common genetic variant within SCN10A modulates cardiac SCN5A expression","volume":"124","author":"van den Boogaard","year":"2014","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.jacep.2021.12.001_bib12","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1161\/CIRCEP.108.789081","article-title":"Cardiac ion channels","volume":"2","author":"Grant","year":"2009","journal-title":"Circ Arrhythmia Electrophysiol"},{"key":"10.1016\/j.jacep.2021.12.001_bib13","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1177\/107385840100700108","article-title":"Sodium channel beta subunits: anything but auxiliary","volume":"7","author":"Isom","year":"2001","journal-title":"Neuroscientist"},{"key":"10.1016\/j.jacep.2021.12.001_bib14","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/j.cardiores.2005.04.003","article-title":"Sodium channels as macromolecular complexes: implications for inherited arrhythmia syndromes","volume":"67","author":"Meadows","year":"2005","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.jacep.2021.12.001_bib15","first-page":"2260","article-title":"Sodium channel \u03b21 subunit mutations associated with Brugada syndrome and cardiac conduction disease in humans","volume":"118","author":"Watanabe","year":"2008","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.jacep.2021.12.001_bib16","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1038\/32675","article-title":"Genetic basis and molecular mechanism for idiopathic ventricular fibrillation","volume":"392","author":"Chen","year":"1998","journal-title":"Nature"},{"key":"10.1016\/j.jacep.2021.12.001_bib17","doi-asserted-by":"crossref","first-page":"H399","DOI":"10.1152\/ajpheart.01025.2005","article-title":"Sodium channel kinetic changes that produce Brugada syndrome or progressive cardiac conduction system disease","volume":"292","author":"Zhang","year":"2007","journal-title":"Am J Physiol Heart Circulatory Physiol"},{"key":"10.1016\/j.jacep.2021.12.001_bib18","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.cardiores.2004.01.022","article-title":"A\u00a0trafficking defective, Brugada syndrome-causing SCN5A mutation rescued by drugs","volume":"62","author":"Valdivia","year":"2004","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.jacep.2021.12.001_bib19","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1161\/CIRCEP.111.000206","article-title":"MOG1 rescues defective trafficking of Na(v)1.5 mutations in Brugada syndrome and sick sinus syndrome","volume":"6","author":"Chakrabarti","year":"2013","journal-title":"Circ Arrhythmia Electrophysiol"},{"key":"10.1016\/j.jacep.2021.12.001_bib20","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.96291","article-title":"Brugada syndrome trafficking-defective Nav1.5 channels can trap cardiac Kir2.1\/2.2 channels","volume":"3","author":"P\u00e9rez-Hern\u00e1ndez","year":"2018","journal-title":"JCI Insight"},{"key":"10.1016\/j.jacep.2021.12.001_bib21","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1161\/01.RES.85.9.803","article-title":"Ionic mechanisms responsible for the electrocardiographic phenotype of the Brugada syndrome are temperature dependent","volume":"85","author":"Dumaine","year":"1999","journal-title":"Circ Res"},{"key":"10.1016\/j.jacep.2021.12.001_bib22","doi-asserted-by":"crossref","first-page":"1873","DOI":"10.1006\/jmcc.2000.1223","article-title":"Functional suppression of sodium channels by beta(1)-subunits as a molecular mechanism of idiopathic ventricular fibrillation","volume":"32","author":"Wan","year":"2000","journal-title":"J\u00a0Mol Cell Cardiol"},{"key":"10.1016\/j.jacep.2021.12.001_bib23","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/j.cardiores.2005.03.024","article-title":"Brugada syndrome and fever: genetic and molecular characterization of patients carrying SCN5A mutations","volume":"67","author":"Keller","year":"2005","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.jacep.2021.12.001_bib24","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/S0008-6363(00)00272-8","article-title":"Cardiac sodium channel and inherited arrhythmia syndromes","volume":"49","author":"Bezzina","year":"2001","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.jacep.2021.12.001_bib25","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1016\/j.hrthm.2009.05.016","article-title":"A\u00a0novel SCN5A mutation V1340I in Brugada syndrome augmenting arrhythmias during febrile illness","volume":"6","author":"Samani","year":"2009","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.jacep.2021.12.001_bib26","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1161\/CIRCULATIONAHA.118.035070","article-title":"Reappraisal of reported genes for sudden arrhythmic death: evidence-based evaluation of gene validity for Brugada syndrome","volume":"138","author":"Hosseini","year":"2018","journal-title":"Circulation"},{"key":"10.1016\/j.jacep.2021.12.001_bib27","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.hrthm.2009.09.069","article-title":"An international compendium of mutations in the SCN5A-encoded cardiac sodium channel in patients referred for Brugada syndrome genetic testing","volume":"7","author":"Kapplinger","year":"2010","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.jacep.2021.12.001_bib28","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.jacc.2014.04.032","article-title":"Mutations in SCN10A are responsible for a large fraction of cases of Brugada syndrome","volume":"64","author":"Hu","year":"2014","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacep.2021.12.001_bib29","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1093\/cvr\/cvv042","article-title":"Role of common and rare variants in SCN10A: results from the Brugada syndrome QRS locus gene discovery collaborative study","volume":"106","author":"Behr","year":"2015","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.jacep.2021.12.001_bib30","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1093\/europace\/euv078","article-title":"Novel SCN10A variants associated with Brugada syndrome","volume":"18","author":"Fukuyama","year":"2016","journal-title":"Europace"},{"key":"10.1016\/j.jacep.2021.12.001_bib31","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1002\/humu.22328","article-title":"A\u00a0missense mutation in the sodium channel \u03b22 subunit reveals SCN2B as a new candidate gene for Brugada syndrome","volume":"34","author":"Riur\u00f3","year":"2013","journal-title":"Hum Mutat"},{"key":"10.1016\/j.jacep.2021.12.001_bib32","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1161\/CIRCULATIONAHA.113.003077","article-title":"Missense mutations in plakophilin-2 cause sodium current deficit and associate with a Brugada syndrome phenotype","volume":"129","author":"Cerrone","year":"2014","journal-title":"Circulation"},{"key":"10.1016\/j.jacep.2021.12.001_bib33","doi-asserted-by":"crossref","first-page":"3081","DOI":"10.1093\/eurheartj\/ehz308","article-title":"RRAD mutation causes electrical and cytoskeletal defects in cardiomyocytes derived from a familial case of Brugada syndrome","volume":"40","author":"Belbachir","year":"2019","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacep.2021.12.001_bib34","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1016\/j.hrthm.2011.02.021","article-title":"Transient outward current (I(to)) gain-of-function mutations in the KCND3-encoded Kv4.3 potassium channel and Brugada syndrome","volume":"8","author":"Giudicessi","year":"2011","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.jacep.2021.12.001_bib35","doi-asserted-by":"crossref","first-page":"1872","DOI":"10.1016\/j.hrthm.2010.08.026","article-title":"Mutations in the cardiac L-type calcium channel associated with inherited J-wave syndromes and sudden cardiac death","volume":"7","author":"Burashnikov","year":"2010","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.jacep.2021.12.001_bib36","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1093\/eurheartj\/ehaa1051","article-title":"Brugada syndrome and reduced right ventricular outflow tract conduction reserve: a final common pathway?","volume":"42","author":"Behr","year":"2021","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacep.2021.12.001_bib37","doi-asserted-by":"crossref","first-page":"2235","DOI":"10.1056\/NEJMsr1406261","article-title":"ClinGen--the Clinical Genome resource","volume":"372","author":"Rehm","year":"2015","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacep.2021.12.001_bib38","doi-asserted-by":"crossref","first-page":"3097","DOI":"10.1093\/eurheartj\/ehz435","article-title":"Predicting cardiac electrical response to sodium-channel blockade and Brugada syndrome using polygenic risk scores","volume":"40","author":"Tadros","year":"2019","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacep.2021.12.001_bib39","article-title":"SCN5A mutation type and a genetic risk score associate variably with Brugada syndrome phenotype in SCN5A families","volume":"13","author":"Wijeyeratne","year":"2020","journal-title":"Circ Genomics Precision Med"},{"key":"10.1016\/j.jacep.2021.12.001_bib40","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1038\/ng.2712","article-title":"Common variants at SCN5A-SCN10A and HEY2 are associated with Brugada syndrome, a rare disease with high risk of sudden cardiac death","volume":"45","author":"Bezzina","year":"2013","journal-title":"Nat Genet"},{"key":"10.1016\/j.jacep.2021.12.001_bib41","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/j.yjmcc.2010.07.012","article-title":"The pathophysiological mechanism underlying Brugada syndrome: depolarization versus repolarization","volume":"49","author":"Wilde","year":"2010","journal-title":"J\u00a0Mol Cell Cardiol"},{"key":"10.1016\/j.jacep.2021.12.001_bib42","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.cardiores.2005.03.005","article-title":"Pathophysiological mechanisms of Brugada syndrome: depolarization disorder, repolarization disorder, or more?","volume":"67","author":"Meregalli","year":"2005","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.jacep.2021.12.001_bib43","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1161\/CIRCEP.108.790543","article-title":"Slow and discontinuous conduction conspire in Brugada syndrome: a right ventricular mapping and stimulation study","volume":"1","author":"Postema","year":"2008","journal-title":"Circ Arrhythmia Electrophysiol"},{"key":"10.1016\/j.jacep.2021.12.001_bib44","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1161\/CIRCULATIONAHA.108.771401","article-title":"High-density substrate mapping in Brugada syndrome: combined role of conduction and repolarization heterogeneities in arrhythmogenesis","volume":"120","author":"Lambiase","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.jacep.2021.12.001_bib45","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.1161\/01.CIR.100.15.1660","article-title":"Cellular basis for the Brugada syndrome and other mechanisms of arrhythmogenesis associated with ST-segment elevation","volume":"100","author":"Yan","year":"1999","journal-title":"Circulation"},{"key":"10.1016\/j.jacep.2021.12.001_bib46","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1161\/01.CIR.0000140258.09964.19","article-title":"Phase 2 reentry as a trigger to initiate ventricular fibrillation during early acute myocardial ischemia","volume":"110","author":"Yan","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.jacep.2021.12.001_bib47","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1016\/j.jacc.2007.10.062","article-title":"Atrial fibrillation and Brugada syndrome","volume":"51","author":"Francis","year":"2008","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacep.2021.12.001_bib48","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1111\/jce.14361","article-title":"Atrial fibrillation in Brugada syndrome: current perspectives","volume":"31","author":"Vlachos","year":"2020","journal-title":"J\u00a0Cardiovasc Electrophysiol"},{"key":"10.1016\/j.jacep.2021.12.001_bib49","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1046\/j.1540-8167.2004.03675.x","article-title":"Relationships between depolarization abnormality and repolarization abnormality in patients with Brugada syndrome: using body surface signal-averaged electrocardiography and body surface maps","volume":"15","author":"Hisamatsu","year":"2004","journal-title":"J\u00a0Cardiovasc Electrophysiol"},{"key":"10.1016\/j.jacep.2021.12.001_bib50","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1111\/j.1540-8159.2006.00505.x","article-title":"Spatial distribution of repolarization and depolarization abnormalities evaluated by body surface potential mapping in patients with Brugada syndrome","volume":"29","author":"Yokokawa","year":"2006","journal-title":"Pacing Clin Electrophysiol"},{"key":"10.1016\/j.jacep.2021.12.001_bib51","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1093\/europace\/eup432","article-title":"Abnormal restitution property of action potential duration and conduction delay in Brugada syndrome: both repolarization and depolarization abnormalities","volume":"12","author":"Nishii","year":"2010","journal-title":"Europace"},{"key":"10.1016\/j.jacep.2021.12.001_bib52","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.1016\/j.jacc.2014.01.072","article-title":"Electrocardiographic parameters and fatal arrhythmic events in patients with Brugada syndrome: combination of depolarization and repolarization abnormalities","volume":"63","author":"Tokioka","year":"2014","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacep.2021.12.001_bib53","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/j.jacc.2009.11.033","article-title":"Local depolarization abnormalities are the dominant pathophysiologic mechanism for type 1 electrocardiogram in brugada syndrome a study of electrocardiograms, vectorcardiograms, and body surface potential maps during ajmaline provocation","volume":"55","author":"Postema","year":"2010","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacep.2021.12.001_bib54","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1161\/01.CIR.103.5.710","article-title":"Right bundle branch block, right precordial ST-segment elevation, and sudden death in young people","volume":"103","author":"Corrado","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.jacep.2021.12.001_bib55","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1093\/ejechocard\/jer139","article-title":"Altered two-dimensional strain measures of the right ventricle in patients with Brugada syndrome and arrhythmogenic right ventricular dysplasia\/cardiomyopathy","volume":"12","author":"Iacoviello","year":"2011","journal-title":"Eur J Echocardiography"},{"key":"10.1016\/j.jacep.2021.12.001_bib56","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/j.hrthm.2016.12.004","article-title":"Late gadolinium enhancement in Brugada syndrome: a marker for subtle underlying cardiomyopathy?","volume":"14","author":"Bastiaenen","year":"2017","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.jacep.2021.12.001_bib57","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0195594","article-title":"Relations between right ventricular morphology and clinical, electrical and genetic parameters in Brugada Syndrome","volume":"13","author":"Gray","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.jacep.2021.12.001_bib58","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.hrthm.2006.10.026","article-title":"Abnormal expression of cardiac neural crest cells in heart development: a different hypothesis for the etiopathogenesis of Brugada syndrome","volume":"4","author":"Elizari","year":"2007","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.jacep.2021.12.001_bib59","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1038\/nrcardio.2016.143","article-title":"Pathogenesis and management of Brugada syndrome","volume":"13","author":"Sieira","year":"2016","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.jacep.2021.12.001_bib60","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1126\/science.6844926","article-title":"Neural crest cells contribute to normal aorticopulmonary septation","volume":"220","author":"Kirby","year":"1983","journal-title":"Science"},{"key":"10.1016\/j.jacep.2021.12.001_bib61","doi-asserted-by":"crossref","first-page":"H1291","DOI":"10.1152\/ajpheart.01017.2006","article-title":"Cardiac neural crest ablation inhibits compaction and electrical function of conduction system bundles","volume":"292","author":"Gurjarpadhye","year":"2007","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.jacep.2021.12.001_bib62","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1161\/CIRCRESAHA.108.188698","article-title":"Developmental basis for electrophysiological heterogeneity in the ventricular and outflow tract myocardium as a substrate for life-threatening ventricular arrhythmias","volume":"104","author":"Boukens","year":"2009","journal-title":"Circ Res"},{"key":"10.1016\/j.jacep.2021.12.001_bib63","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/S0092-8674(00)81282-9","article-title":"The gap junction communication channel","volume":"84","author":"Kumar","year":"1996","journal-title":"Cell"},{"key":"10.1016\/j.jacep.2021.12.001_bib64","doi-asserted-by":"crossref","first-page":"1976","DOI":"10.1016\/j.jacc.2015.08.862","article-title":"Fibrosis, Connexin-43, and conduction abnormalities in the Brugada syndrome","volume":"66","author":"Nademanee","year":"2015","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacep.2021.12.001_bib65","doi-asserted-by":"crossref","first-page":"2747","DOI":"10.1016\/j.jacc.2018.09.037","article-title":"Electroanatomic and pathologic right ventricular outflow tract abnormalities in patients with Brugada syndrome","volume":"72","author":"Pieroni","year":"2018","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacep.2021.12.001_bib66","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1161\/CIRCULATIONAHA.110.972612","article-title":"Prevention of ventricular fibrillation episodes in Brugada syndrome by catheter ablation over the anterior right ventricular outflow tract epicardium","volume":"123","author":"Nademanee","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.jacep.2021.12.001_bib67","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1161\/CIRCULATIONAHA.115.017885","article-title":"Programmed ventricular stimulation for risk stratification in the Brugada syndrome: a pooled analysis","volume":"133","author":"Sroubek","year":"2016","journal-title":"Circulation"},{"key":"10.1016\/j.jacep.2021.12.001_bib68","doi-asserted-by":"crossref","first-page":"2042","DOI":"10.1161\/CIRCULATIONAHA.106.664219","article-title":"Clinical aspects and prognosis of Brugada syndrome in children","volume":"115","author":"Probst","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.jacep.2021.12.001_bib69","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.1016\/j.jacc.2019.01.048","article-title":"Characterization and management of arrhythmic events in young patients with Brugada syndrome","volume":"73","author":"Michowitz","year":"2019","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacep.2021.12.001_bib70","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.jacc.2005.03.066","article-title":"Developmental aspects of long QT syndrome type 3 and Brugada syndrome on the basis of a single SCN5A mutation in childhood","volume":"46","author":"Beaufort-Krol","year":"2005","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacep.2021.12.001_bib71","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1111\/j.1540-8159.2005.40020.x","article-title":"Prevalence and clinical course of the juveniles with Brugada-type ECG in Japanese population","volume":"28","author":"Oe","year":"2005","journal-title":"Pacing Clin Electrophysiol"},{"key":"10.1016\/j.jacep.2021.12.001_bib72","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1016\/j.jacc.2018.01.031","article-title":"The diagnostic yield of Brugada syndrome after sudden death with normal autopsy","volume":"71","author":"Papadakis","year":"2018","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacep.2021.12.001_bib73","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1161\/CIRCULATIONAHA.109.853143","article-title":"Systematic assessment of patients with unexplained cardiac arrest: Cardiac Arrest Survivors With Preserved Ejection Fraction Registry (CASPER)","volume":"120","author":"Krahn","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.jacep.2021.12.001_bib74","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1016\/j.hrthm.2010.05.036","article-title":"Diagnostic yield in sudden unexplained death and aborted cardiac arrest in the young: the experience of a tertiary referral center in The Netherlands","volume":"7","author":"van der Werf","year":"2010","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.jacep.2021.12.001_bib75","doi-asserted-by":"crossref","first-page":"2514","DOI":"10.1161\/01.CIR.0000034169.45752.4A","article-title":"Proposed diagnostic criteria for the Brugada syndrome: consensus report","volume":"106","author":"Wilde","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.jacep.2021.12.001_bib76","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1161\/01.CIR.0000152479.54298.51","article-title":"Brugada syndrome: report of the second consensus conference: endorsed by the Heart Rhythm Society and the European Heart Rhythm Association","volume":"111","author":"Antzelevitch","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.jacep.2021.12.001_bib77","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.1016\/j.hrthm.2013.05.014","article-title":"HRS\/EHRA\/APHRS expert consensus statement on the diagnosis and management of patients with inherited primary arrhythmia syndromes: document endorsed by HRS, EHRA, and APHRS in May 2013 and by ACCF, AHA, PACES, and AEPC in June 2013","volume":"10","author":"Priori","year":"2013","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.jacep.2021.12.001_bib78","doi-asserted-by":"crossref","first-page":"e295","DOI":"10.1016\/j.hrthm.2016.05.024","article-title":"J-Wave syndromes expert consensus conference report: emerging concepts and gaps in knowledge","volume":"13","author":"Antzelevitch","year":"2016","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.jacep.2021.12.001_bib79","first-page":"267","article-title":"Acute management of ventricular arrhythmia in patients with suspected inherited heart rhythm disorders","volume":"5","author":"Laksman","year":"2019","journal-title":"J\u00a0Am Coll Cardiol EP"},{"key":"10.1016\/j.jacep.2021.12.001_bib80","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.ijcard.2015.02.044","article-title":"VERP in Brugada syndrome - very effective risk predictor?","volume":"184","author":"Zuberi","year":"2015","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.jacep.2021.12.001_bib81","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/j.hrthm.2015.10.038","article-title":"Monomorphic ventricular tachycardia in patients with Brugada syndrome: a multicenter retrospective study","volume":"13","author":"Rodr\u00edguez-Ma\u00f1ero","year":"2016","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.jacep.2021.12.001_bib82","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/j.hrthm.2015.11.039","article-title":"Monomorphic ventricular tachycardia in Brugada syndrome: true-true but related?","volume":"13","author":"Eckhardt","year":"2016","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.jacep.2021.12.001_bib83","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCEP.117.005222","article-title":"Age of first arrhythmic event in Brugada syndrome: data from the SABRUS (Survey on Arrhythmic Events in Brugada Syndrome) in 678 patients","volume":"10","author":"Milman","year":"2017","journal-title":"Circ Arrhythmia Electrophysiol"},{"key":"10.1016\/j.jacep.2021.12.001_bib84","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1161\/CIRCULATIONAHA.111.054007","article-title":"Brugada-like syndrome in infancy presenting with rapid ventricular tachycardia and intraventricular conduction delay","volume":"125","author":"Kanter","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.jacep.2021.12.001_bib85","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1016\/j.hrthm.2016.02.013","article-title":"Impact of clinical and genetic findings on the management of young patients with Brugada syndrome","volume":"13","author":"Andorin","year":"2016","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.jacep.2021.12.001_bib86","first-page":"1864","article-title":"Brugada syndrome in the young: an assessment of risk factors predicting future events","volume":"19","author":"Gonzalez Corcia","year":"2017","journal-title":"Europace"},{"key":"10.1016\/j.jacep.2021.12.001_bib87","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1016\/j.jacc.2016.05.073","article-title":"Long-term trends in newly diagnosed Brugada syndrome: implications for risk stratification","volume":"68","author":"Casado-Arroyo","year":"2016","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacep.2021.12.001_bib88","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.hrthm.2014.10.014","article-title":"Syncope in Brugada syndrome: prevalence, clinical significance, and clues from history taking to distinguish arrhythmic from nonarrhythmic causes","volume":"12","author":"Olde Nordkamp","year":"2015","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.jacep.2021.12.001_bib89","doi-asserted-by":"crossref","first-page":"113","DOI":"10.5694\/mja17.01117","article-title":"Brugada syndrome and undifferentiated syncope: use of an implantable loop recorder to document causation","volume":"209","author":"Hamilton","year":"2018","journal-title":"Medical J Australia"},{"key":"10.1016\/j.jacep.2021.12.001_bib90","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1016\/0735-1097(95)00613-3","article-title":"Autonomic and antiarrhythmic drug modulation of ST segment elevation in patients with Brugada syndrome","volume":"27","author":"Miyazaki","year":"1996","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacep.2021.12.001_bib91","doi-asserted-by":"crossref","first-page":"216","DOI":"10.7326\/0003-4819-149-3-200808050-00020","article-title":"Fever increases the risk for cardiac arrest in the Brugada syndrome","volume":"149","author":"Amin","year":"2008","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jacep.2021.12.001_bib92","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1111\/j.1540-8167.2007.00972.x","article-title":"Influence of meals on variations of ST segment elevation in patients with Brugada syndrome","volume":"19","author":"Nishizaki","year":"2008","journal-title":"J\u00a0Cardiovasc Electrophysiol"},{"key":"10.1016\/j.jacep.2021.12.001_bib93","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1016\/j.hrthm.2009.07.002","article-title":"Drugs and Brugada syndrome patients: review of the literature, recommendations, and an up-to-date website (www.brugadadrugs.org)","volume":"6","author":"Postema","year":"2009","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.jacep.2021.12.001_bib94","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1093\/europace\/eup114","article-title":"Drug-induced Brugada syndrome","volume":"11","author":"Yap","year":"2009","journal-title":"Europace"},{"key":"10.1016\/j.jacep.2021.12.001_bib95","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1016\/j.hrthm.2013.07.030","article-title":"Fever-induced Brugada pattern: how common is it and what does it mean?","volume":"10","author":"Adler","year":"2013","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.jacep.2021.12.001_bib96","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1093\/europace\/eut009","article-title":"Alcohol-induced ventricular fibrillation in a case of Brugada syndrome","volume":"15","author":"Ohkubo","year":"2013","journal-title":"Europace"},{"key":"10.1016\/j.jacep.2021.12.001_bib97","doi-asserted-by":"crossref","first-page":"2317","DOI":"10.1161\/CIRCULATIONAHA.106.628537","article-title":"Outcome after implantation of a cardioverter-defibrillator in patients with Brugada syndrome: a multicenter study","volume":"114","author":"Sacher","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.jacep.2021.12.001_bib98","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.hrthm.2013.10.043","article-title":"Atrial fibrillation in a large population with Brugada electrocardiographic pattern: prevalence, management, and correlation with prognosis","volume":"11","author":"Giustetto","year":"2014","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.jacep.2021.12.001_bib99","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.hrthm.2011.10.032","article-title":"Insights into the location of type I ECG in patients with Brugada syndrome: correlation of ECG and cardiovascular magnetic resonance imaging","volume":"9","author":"Veltmann","year":"2012","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.jacep.2021.12.001_bib100","doi-asserted-by":"crossref","first-page":"2290","DOI":"10.1053\/euhj.2001.2691","article-title":"New electrocardiographic leads and the procainamide test for the detection of the Brugada sign in sudden unexplained death syndrome survivors and their relatives","volume":"22","author":"Sangwatanaroj","year":"2001","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacep.2021.12.001_bib101","doi-asserted-by":"crossref","first-page":"1904","DOI":"10.1136\/hrt.2010.201244","article-title":"Utility of high and standard right precordial leads during ajmaline testing for the diagnosis of Brugada syndrome","volume":"96","author":"Govindan","year":"2010","journal-title":"Heart"},{"key":"10.1016\/j.jacep.2021.12.001_bib102","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1161\/CIRCEP.111.965947","article-title":"How to perform and interpret provocative testing for the diagnosis of Brugada syndrome, long-QT syndrome, and catecholaminergic polymorphic ventricular tachycardia","volume":"4","author":"Obeyesekere","year":"2011","journal-title":"Circ Arrhythmia Electrophysiol"},{"key":"10.1016\/j.jacep.2021.12.001_bib103","doi-asserted-by":"crossref","first-page":"2228","DOI":"10.1161\/CIRCULATIONAHA.105.552166","article-title":"Diagnosis of unexplained cardiac arrest: role of adrenaline and procainamide infusion","volume":"112","author":"Krahn","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.jacep.2021.12.001_bib104","first-page":"504","article-title":"Comparison of ajmaline and procainamide provocation tests in the diagnosis of Brugada syndrome","volume":"5","author":"Cheung","year":"2019","journal-title":"J\u00a0Am Clin Cardiol EP"},{"key":"10.1016\/j.jacep.2021.12.001_bib105","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1038\/nrd2112","article-title":"Innovative approaches to anti-arrhythmic drug therapy","volume":"5","author":"Nattel","year":"2006","journal-title":"Nat Rev Drug Disc"},{"key":"10.1016\/j.jacep.2021.12.001_bib106","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1161\/CIRCULATIONAHA.118.035455","article-title":"Modernized classification of cardiac antiarrhythmic drugs","volume":"138","author":"Lei","year":"2018","journal-title":"Circulation"},{"key":"10.1016\/j.jacep.2021.12.001_bib107","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1002\/j.1552-4604.1984.tb01822.x","article-title":"A\u00a0classification of antiarrhythmic actions reassessed after a decade of new drugs","volume":"24","author":"Vaughan Williams","year":"1984","journal-title":"J\u00a0Clin Pharmacol"},{"key":"10.1016\/j.jacep.2021.12.001_bib108","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/S0006-291X(03)00980-X","article-title":"Characterisation of recombinant HERG K+ channel blockade by the Class Ia antiarrhythmic drug procainamide","volume":"306","author":"Ridley","year":"2003","journal-title":"Biochem Biophys Res Comm"},{"key":"10.1016\/j.jacep.2021.12.001_bib109","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1111\/j.1476-5381.2010.00816.x","article-title":"Molecular determinants of state-dependent block of voltage-gated sodium channels by pilsicainide","volume":"160","author":"Desaphy","year":"2010","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.jacep.2021.12.001_bib110","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.scr.2017.11.003","article-title":"Ajmaline blocks I(Na) and I(Kr) without eliciting differences between Brugada syndrome patient and control human pluripotent stem cell-derived cardiac clusters","volume":"25","author":"Miller","year":"2017","journal-title":"Stem Cell Res"},{"key":"10.1016\/j.jacep.2021.12.001_bib111","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1111\/bph.13807","article-title":"Multiple targets for flecainide action: implications for cardiac arrhythmogenesis","volume":"175","author":"Salvage","year":"2018","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.jacep.2021.12.001_bib112","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.ijcard.2017.05.099","article-title":"Value of the sodium-channel blocker challenge in Brugada syndrome","volume":"245","author":"Therasse","year":"2017","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.jacep.2021.12.001_bib113","first-page":"1400","article-title":"Yield and pitfalls of ajmaline testing in the evaluation of unexplained cardiac arrest and sudden unexplained death: single-center experience with 482 families","volume":"3","author":"Tadros","year":"2017","journal-title":"J\u00a0Am Coll Cardiol EP"},{"key":"10.1016\/j.jacep.2021.12.001_bib114","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.1016\/j.hrthm.2015.03.015","article-title":"High prevalence of concealed Brugada syndrome in patients with atrioventricular nodal reentrant tachycardia","volume":"12","author":"Hasdemir","year":"2015","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.jacep.2021.12.001_bib115","first-page":"232","article-title":"Recommendations for the use of genetic testing in the clinical evaluation of inherited cardiac arrhythmias associated with sudden cardiac death: Canadian Cardiovascular Society\/Canadian Heart Rhythm Society joint position paper","volume":"27","author":"Gollob","year":"2011","journal-title":"Canadian J Cardiol"},{"key":"10.1016\/j.jacep.2021.12.001_bib116","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1161\/CIRCGENETICS.109.853374","article-title":"SCN5A mutations and the role of genetic background in the pathophysiology of Brugada syndrome","volume":"2","author":"Probst","year":"2009","journal-title":"Circ Cardiovasc Genet"},{"key":"10.1016\/j.jacep.2021.12.001_bib117","doi-asserted-by":"crossref","first-page":"2757","DOI":"10.1093\/hmg\/ddv036","article-title":"Testing the burden of rare variation in arrhythmia-susceptibility genes provides new insights into molecular diagnosis for Brugada syndrome","volume":"24","author":"Le Scouarnec","year":"2015","journal-title":"Hum Molec Genet"},{"key":"10.1016\/j.jacep.2021.12.001_bib118","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1161\/CIRCEP.114.001818","article-title":"Cardiac evaluation of pediatric relatives in sudden arrhythmic death syndrome: a 2-center experience","volume":"7","author":"Wong","year":"2014","journal-title":"Circ Arrhythmia Electrophysiol"},{"key":"10.1016\/j.jacep.2021.12.001_bib119","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1016\/j.hrthm.2017.06.031","article-title":"Sodium-channel blocker challenge in the familial screening of Brugada syndrome: safety and predictors of positivity","volume":"14","author":"Therasse","year":"2017","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.jacep.2021.12.001_bib120","doi-asserted-by":"crossref","DOI":"10.1136\/openhrt-2013-000023","article-title":"Feasibility and outcomes of ajmaline provocation testing for Brugada syndrome in children in a specialist paediatric inherited cardiovascular diseases centre","volume":"1","author":"McMillan","year":"2014","journal-title":"Open Heart"},{"key":"10.1016\/j.jacep.2021.12.001_bib121","doi-asserted-by":"crossref","first-page":"2272","DOI":"10.1016\/j.jacc.2014.02.574","article-title":"Drug-induced brugada syndrome in children: clinical features, device-based management, and long-term follow-up","volume":"63","author":"Conte","year":"2014","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacep.2021.12.001_bib122","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1007\/s00392-019-01450-w","volume":"108","author":"Heermann","year":"2019","journal-title":"Clin Res Cardiol"},{"key":"10.1016\/j.jacep.2021.12.001_bib123","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1161\/hc1102.105288","article-title":"Natural history of Brugada syndrome: insights for risk stratification and management","volume":"105","author":"Priori","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.jacep.2021.12.001_bib124","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.jacc.2011.08.064","article-title":"Risk stratification in Brugada syndrome: results of the PRELUDE (PRogrammed ELectrical stimUlation preDictive valuE) registry","volume":"59","author":"Priori","year":"2012","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacep.2021.12.001_bib125","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1161\/CIRCULATIONAHA.109.887026","article-title":"Long-term prognosis of patients diagnosed with Brugada syndrome: results from the FINGER Brugada Syndrome Registry","volume":"121","author":"Probst","year":"2010","journal-title":"Circulation"},{"key":"10.1016\/j.jacep.2021.12.001_bib126","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1093\/eurheartj\/ehq381","article-title":"Risk stratification in individuals with the Brugada type 1 ECG pattern without previous cardiac arrest: usefulness of a combined clinical and electrophysiologic approach","volume":"32","author":"Delise","year":"2011","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacep.2021.12.001_bib127","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/j.hrthm.2012.12.023","article-title":"The prognostic value of early repolarization (J wave) and ST-segment morphology after J wave in Brugada syndrome: multicenter study in Japan","volume":"10","author":"Takagi","year":"2013","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.jacep.2021.12.001_bib128","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1253\/circj.CJ-14-1059","article-title":"Risk stratification in patients with Brugada syndrome without previous cardiac arrest \u2013 prognostic value of combined risk factors","volume":"79","author":"Okamura","year":"2015","journal-title":"Circ J"},{"key":"10.1016\/j.jacep.2021.12.001_bib129","doi-asserted-by":"crossref","first-page":"1947","DOI":"10.1016\/j.hrthm.2016.07.009","article-title":"Risk stratification of ventricular fibrillation in Brugada syndrome using noninvasive scoring methods","volume":"13","author":"Kawazoe","year":"2016","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.jacep.2021.12.001_bib130","article-title":"Prognostic significance of the sodium channel blocker test in patients with Brugada syndrome","volume":"7","author":"Ueoka","year":"2018","journal-title":"J\u00a0Am Heart Assoc"},{"key":"10.1016\/j.jacep.2021.12.001_bib131","first-page":"210","article-title":"A\u00a0primary prevention clinical risk score model for patients with Brugada syndrome (BRUGADA-RISK)","volume":"7","author":"Honarbakhsh","year":"2021","journal-title":"J\u00a0Am Coll Cardiol EP"},{"key":"10.1016\/j.jacep.2021.12.001_bib132","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.hrthm.2018.08.032","article-title":"Clinical presentation and follow-up of women affected by Brugada syndrome","volume":"16","author":"Berthome","year":"2019","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.jacep.2021.12.001_bib133","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1016\/j.hrthm.2013.03.001","article-title":"Prevalence, characteristics, and prognosis role of type 1 ST elevation in the peripheral ECG leads in patients with Brugada syndrome","volume":"10","author":"Rollin","year":"2013","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.jacep.2021.12.001_bib134","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.amjcard.2015.03.044","article-title":"Meta-analysis on risk stratification of asymptomatic individuals with the Brugada phenotype","volume":"116","author":"Letsas","year":"2015","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacep.2021.12.001_bib135","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.jelectrocard.2019.04.006","article-title":"A\u00a0novel prediction model for risk stratification in patients with a type 1 Brugada ECG pattern","volume":"55","author":"Subramanian","year":"2019","journal-title":"J\u00a0Electrocardiol"},{"key":"10.1016\/j.jacep.2021.12.001_bib136","doi-asserted-by":"crossref","first-page":"2474","DOI":"10.1111\/jce.14631","article-title":"The utility of drug challenge testing in Brugada syndrome: a systematic review and meta-analysis","volume":"31","author":"Rattanawong","year":"2020","journal-title":"J\u00a0Cardiovasc Electrophysiol"},{"key":"10.1016\/j.jacep.2021.12.001_bib137","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1016\/j.jacc.2016.01.024","article-title":"A\u00a0new electrocardiographic marker of sudden death in Brugada syndrome: the S-Wave in lead I","volume":"67","author":"Cal\u00f2","year":"2016","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacep.2021.12.001_bib138","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/j.hrthm.2019.11.027","article-title":"Age at diagnosis of Brugada syndrome: influence on clinical characteristics and risk of arrhythmia","volume":"17","author":"Minier","year":"2020","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.jacep.2021.12.001_bib139","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/j.amjcard.2017.05.056","article-title":"A\u00a0clinical score model to predict lethal events in young patients (\u226419 years) with the Brugada syndrome","volume":"120","author":"Gonzalez Corcia","year":"2017","journal-title":"Am J Cardiol"},{"issue":"Suppl 2","key":"10.1016\/j.jacep.2021.12.001_bib140","doi-asserted-by":"crossref","first-page":"ii54","DOI":"10.1093\/europace\/euv141","article-title":"Prevalence and prognosis of Brugada electrocardiogram patterns in an elderly Han Chinese population: a nation-wide community-based study (HALST cohort)","volume":"17","author":"Juang","year":"2015","journal-title":"Europace"},{"key":"10.1016\/j.jacep.2021.12.001_bib141","first-page":"57","article-title":"Clinical characteristics and long-term prognosis of senior patients with Brugada syndrome","volume":"3","author":"Kitamura","year":"2017","journal-title":"J\u00a0Am Coll Cardiol EP"},{"key":"10.1016\/j.jacep.2021.12.001_bib142","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.3389\/fphys.2018.01127","article-title":"Gender differences in prognosis and risk stratification of Brugada syndrome: a pooled analysis of 4,140 patients from 24 clinical trials","volume":"9","author":"Yuan","year":"2018","journal-title":"Front Physiol"},{"key":"10.1016\/j.jacep.2021.12.001_bib143","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1136\/heartjnl-2015-308556","article-title":"Clinical characterisation and long-term prognosis of women with Brugada syndrome","volume":"102","author":"Sieira","year":"2016","journal-title":"Heart"},{"key":"10.1016\/j.jacep.2021.12.001_bib144","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1161\/CIRCEP.108.816892","article-title":"Long-term prognosis of probands with Brugada-pattern ST-elevation in leads V1-V3","volume":"2","author":"Kamakura","year":"2009","journal-title":"Circ Arrhythmia Electrophysiol"},{"key":"10.1016\/j.jacep.2021.12.001_bib145","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.1093\/eurheartj\/ehx119","article-title":"A\u00a0score model to predict risk of events in patients with Brugada syndrome","volume":"38","author":"Sieira","year":"2017","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacep.2021.12.001_bib146","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1016\/j.hrthm.2013.04.010","article-title":"Brugada burden in Brugada syndrome: the way to go in risk stratification?","volume":"10","author":"Viskin","year":"2013","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.jacep.2021.12.001_bib147","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.ijcard.2018.08.089","article-title":"Multiple serial ECGs aid with the diagnosis and prognosis of Brugada syndrome","volume":"277","author":"Castro Hevia","year":"2019","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.jacep.2021.12.001_bib148","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1016\/j.hrthm.2017.02.026","article-title":"Twelve-lead ambulatory electrocardiographic monitoring in Brugada syndrome: potential diagnostic and prognostic implications","volume":"14","author":"Gray","year":"2017","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.jacep.2021.12.001_bib149","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1161\/CIRCULATIONAHA.108.770917","article-title":"Fragmented QRS as a marker of conduction abnormality and a predictor of prognosis of Brugada syndrome","volume":"118","author":"Morita","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.jacep.2021.12.001_bib150","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1016\/j.amjcard.2017.01.039","article-title":"Long-term follow-up of probands with Brugada syndrome","volume":"119","author":"de Asmundis","year":"2017","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacep.2021.12.001_bib151","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1111\/j.1540-8167.2007.00971.x","article-title":"Clinical characteristics and risk stratification in symptomatic and asymptomatic patients with brugada syndrome: multicenter study in Japan","volume":"18","author":"Takagi","year":"2007","journal-title":"J\u00a0Cardiovasc Electrophysiol"},{"key":"10.1016\/j.jacep.2021.12.001_bib152","first-page":"1355.e1","article-title":"Predictors of ventricular arrhythmias and sudden death in a Qu\u00e9bec cohort with Brugada syndrome","volume":"32","author":"Rivard","year":"2016","journal-title":"Canadian J Cardiol"},{"key":"10.1016\/j.jacep.2021.12.001_bib153","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1111\/jce.14848","article-title":"Risk stratification in asymptomatic patients with Brugada syndrome: utility of multiple risk factor combination rather than programmed electrical stimulation","volume":"32","author":"Shinohara","year":"2021","journal-title":"J\u00a0Cardiovasc Electrophysiol"},{"key":"10.1016\/j.jacep.2021.12.001_bib154","article-title":"Incorporating latent variables using nonnegative matrix factorization improves risk stratification in Brugada syndrome","volume":"9","author":"Tse","year":"2020","journal-title":"J\u00a0Am Heart Assoc"},{"key":"10.1016\/j.jacep.2021.12.001_bib155","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.ijcard.2019.11.121","article-title":"Ventricular conduction delay as marker of risk in Brugada Syndrome. Results from the analysis of clinical and electrocardiographic features of a large cohort of patients","volume":"302","author":"Giustetto","year":"2020","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.jacep.2021.12.001_bib156","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1161\/CIRCEP.108.795153","article-title":"Inferior and lateral electrocardiographic repolarization abnormalities in Brugada syndrome","volume":"2","author":"Sarkozy","year":"2009","journal-title":"Circ Arrhythmia Electrophysiol"},{"key":"10.1016\/j.jacep.2021.12.001_bib157","first-page":"1866","article-title":"Tpeak-Tend interval and Tpeak-Tend\/QT ratio in patients with Brugada syndrome","volume":"18","author":"Zumhagen","year":"2016","journal-title":"Europace"},{"key":"10.1016\/j.jacep.2021.12.001_bib158","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1016\/S0735-1097(01)01197-4","article-title":"Assessment of noninvasive markers in identifying patients at risk in the Brugada syndrome: insight into risk stratification","volume":"37","author":"Ikeda","year":"2001","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacep.2021.12.001_bib159","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1016\/j.hrthm.2009.05.007","article-title":"Role of signal-averaged electrocardiograms in arrhythmic risk stratification of patients with Brugada syndrome: a prospective study","volume":"6","author":"Huang","year":"2009","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.jacep.2021.12.001_bib160","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1046\/j.1540-8167.2003.02517.x","article-title":"Natural history of Brugada syndrome: the prognostic value of programmed electrical stimulation of the heart","volume":"14","author":"Brugada","year":"2003","journal-title":"J\u00a0Cardiovasc Electrophysiol"},{"key":"10.1016\/j.jacep.2021.12.001_bib161","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1016\/j.jacc.2014.12.031","article-title":"Implantable cardioverter-defibrillator therapy in Brugada syndrome: a 20-year single-center experience","volume":"65","author":"Conte","year":"2015","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacep.2021.12.001_bib162","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1161\/CIRCEP.114.003044","article-title":"Asymptomatic Brugada syndrome: clinical characterization and long-term prognosis","volume":"8","author":"Sieira","year":"2015","journal-title":"Circ Arrhythmia Electrophysiol"},{"key":"10.1016\/j.jacep.2021.12.001_bib163","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1016\/S0735-1097(87)80465-5","article-title":"Risks and complications of clinical cardiac electrophysiologic studies: a prospective analysis of 1,000 consecutive patients","volume":"9","author":"Horowitz","year":"1987","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacep.2021.12.001_bib164","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1046\/j.1540-8167.2002.00880.x","article-title":"Programmed electrical stimulation in Brugada syndrome: how reproducible are the results?","volume":"13","author":"Gasparini","year":"2002","journal-title":"J\u00a0Cardiovasc Electrophysiol"},{"key":"10.1016\/j.jacep.2021.12.001_bib165","doi-asserted-by":"crossref","first-page":"2255","DOI":"10.1161\/CIRCULATIONAHA.117.027983","article-title":"Genotype-phenotype correlation of SCN5A mutation for the clinical and electrocardiographic characteristics of probands with Brugada syndrome: a Japanese multicenter registry","volume":"135","author":"Yamagata","year":"2017","journal-title":"Circulation"},{"key":"10.1016\/j.jacep.2021.12.001_bib166","article-title":"SCN5A genetic polymorphisms associated with increased defibrillator shocks in Brugada syndrome","volume":"6","author":"Makarawate","year":"2017","journal-title":"J\u00a0Am Heart Assoc"},{"key":"10.1016\/j.jacep.2021.12.001_bib167","doi-asserted-by":"crossref","first-page":"103","DOI":"10.3389\/fphys.2019.00103","article-title":"Meta-analysis of risk stratification of SCN5A with Brugada syndrome: is SCN5A always a marker of low risk?","volume":"10","author":"Yang","year":"2019","journal-title":"Front Physiol"},{"key":"10.1016\/j.jacep.2021.12.001_bib168","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1111\/cge.13552","article-title":"Brugada syndrome with SCN5A mutations exhibits more pronounced electrophysiological defects and more severe prognosis: a meta-analysis","volume":"97","author":"Chen","year":"2020","journal-title":"Clin Genet"},{"key":"10.1016\/j.jacep.2021.12.001_bib169","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1093\/eurheartj\/ehaa763","article-title":"Robustness and relevance of predictive score in sudden cardiac death for patients with Brugada syndrome","volume":"42","author":"Probst","year":"2020","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacep.2021.12.001_bib170","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1111\/anec.12288","article-title":"Fever-induced Brugada syndrome is more common than previously suspected: a cross-sectional study from an endemic area","volume":"21","author":"Rattanawong","year":"2016","journal-title":"Ann Noninvasive Electrocardiol"},{"key":"10.1016\/j.jacep.2021.12.001_bib171","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1016\/j.hrthm.2018.04.007","article-title":"Fever-related arrhythmic events in the multicenter survey on arrhythmic events in Brugada syndrome","volume":"15","author":"Michowitz","year":"2018","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.jacep.2021.12.001_bib172","first-page":"752","article-title":"Genetic variants of alcohol-metabolizing enzymes in Brugada syndrome: insights into syncope after drinking alcohol","volume":"35","author":"Wu","year":"2019","journal-title":"J\u00a0Arrhythmia"},{"key":"10.1016\/j.jacep.2021.12.001_bib173","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1253\/circj.67.93","article-title":"Brugada syndrome with ventricular tachycardia and fibrillation related to hypokalemia","volume":"67","author":"Araki","year":"2003","journal-title":"Circ J"},{"key":"10.1016\/j.jacep.2021.12.001_bib174","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1093\/europace\/eur151","article-title":"Familial Brugada syndrome uncovered by hyperkalaemic diabetic ketoacidosis","volume":"13","author":"Postema","year":"2011","journal-title":"Europace"},{"key":"10.1016\/j.jacep.2021.12.001_bib175","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1161\/01.CIR.0000143159.30585.90","article-title":"Efficacy of quinidine in high-risk patients with Brugada syndrome","volume":"110","author":"Belhassen","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.jacep.2021.12.001_bib176","doi-asserted-by":"crossref","first-page":"1853","DOI":"10.1016\/j.jacc.2003.12.046","article-title":"Hydroquinidine therapy in Brugada syndrome","volume":"43","author":"Hermida","year":"2004","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacep.2021.12.001_bib177","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1111\/j.1540-8167.2010.01907.x","article-title":"Successful use of quinine in the treatment of electrical storm in a child with Brugada syndrome","volume":"22","author":"Mehrotra","year":"2011","journal-title":"J\u00a0Cardiovas Electrophysiol"},{"key":"10.1016\/j.jacep.2021.12.001_bib178","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.phrs.2019.04.028","article-title":"Quinidine-A legacy within the modern era of antiarrhythmic therapy","volume":"144","author":"Vitali Serdoz","year":"2019","journal-title":"Pharmacological Res"},{"key":"10.1016\/j.jacep.2021.12.001_bib179","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.amjmed.2008.11.019","article-title":"Quinidine revisited","volume":"122","author":"Yang","year":"2009","journal-title":"Am J Med"},{"key":"10.1016\/j.jacep.2021.12.001_bib180","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1161\/CIRCEP.115.003109","article-title":"Management of Brugada syndrome: thirty-three-year experience using electrophysiologically guided therapy with class 1A antiarrhythmic drugs","volume":"8","author":"Belhassen","year":"2015","journal-title":"Circ Arrhythmia Electrophysiol"},{"key":"10.1016\/j.jacep.2021.12.001_bib181","doi-asserted-by":"crossref","first-page":"2383","DOI":"10.1016\/j.jacc.2013.02.077","article-title":"Quinidine, a life-saving medication for Brugada syndrome, is inaccessible in many countries","volume":"61","author":"Viskin","year":"2013","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacep.2021.12.001_bib182","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1016\/j.hrthm.2017.04.019","article-title":"The QUIDAM study: hydroquinidine therapy for the management of Brugada syndrome patients at high arrhythmic risk","volume":"14","author":"Andorin","year":"2017","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.jacep.2021.12.001_bib183","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1016\/j.jacc.2016.01.042","article-title":"Shock reduction with long-term quinidine in patients with Brugada syndrome and malignant ventricular arrhythmia episodes","volume":"67","author":"Anguera","year":"2016","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacep.2021.12.001_bib184","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.hrcr.2018.01.008","article-title":"Quinidine effective for the management of ventricular and atrial arrhythmias associated with Brugada syndrome","volume":"4","author":"Halperin","year":"2018","journal-title":"HeartRhythm Case Rep"},{"key":"10.1016\/j.jacep.2021.12.001_bib185","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1016\/j.hrthm.2012.08.027","article-title":"Long-term efficacy of low doses of quinidine on malignant arrhythmias in Brugada syndrome with an implantable cardioverter-defibrillator: a case series and literature review","volume":"9","author":"M\u00e1rquez","year":"2012","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.jacep.2021.12.001_bib186","doi-asserted-by":"crossref","first-page":"e12375","DOI":"10.1111\/anec.12375","article-title":"Low-dose quinidine effectively reduced shocks in Brugada syndrome patients with an implantable cardioverter defibrillator: a Chinese case series report","volume":"22","author":"Shen","year":"2017","journal-title":"Ann Noninvasive Electrocardiol"},{"key":"10.1016\/j.jacep.2021.12.001_bib187","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.eupc.2003.11.009","article-title":"Electrical storm in Brugada syndrome successfully treated using isoprenaline","volume":"6","author":"Maury","year":"2004","journal-title":"Europace"},{"key":"10.1016\/j.jacep.2021.12.001_bib188","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1161\/CIRCEP.114.001806","article-title":"Electrical storm in patients with brugada syndrome is associated with early repolarization","volume":"7","author":"Kaneko","year":"2014","journal-title":"Circ Arrhythmia Electrophysiol"},{"key":"10.1016\/j.jacep.2021.12.001_bib189","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1016\/j.hrthm.2013.07.047","article-title":"Cellular mechanisms underlying the effects of milrinone and cilostazol to suppress arrhythmogenesis associated with Brugada syndrome","volume":"10","author":"Sz\u00e9l","year":"2013","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.jacep.2021.12.001_bib190","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1016\/j.jacc.2017.10.053","volume":"72","author":"Al-Khatib","year":"2018","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacep.2021.12.001_bib191","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.hrthm.2015.09.010","article-title":"Implantable cardioverter-defibrillator harm in young patients with inherited arrhythmia syndromes: a systematic review and meta-analysis of inappropriate shocks and complications","volume":"13","author":"Olde Nordkamp","year":"2016","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.jacep.2021.12.001_bib192","first-page":"141","article-title":"Meta-analysis of clinical outcome after implantable cardioverter-defibrillator implantation in patients with Brugada syndrome","volume":"5","author":"Dereci","year":"2019","journal-title":"J\u00a0Am Coll Cardiol EP"},{"key":"10.1016\/j.jacep.2021.12.001_bib193","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1093\/europace\/eur319","article-title":"Use of implantable loop recorders in patients with Brugada syndrome and suspected risk of ventricular arrhythmia","volume":"14","author":"Kubala","year":"2012","journal-title":"Europace"},{"key":"10.1016\/j.jacep.2021.12.001_bib194","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1093\/europace\/euaa370","article-title":"Brugada syndrome and syncope: a practical approach for diagnosis and treatment","volume":"23","author":"Mascia","year":"2021","journal-title":"Europace"},{"issue":"1","key":"10.1016\/j.jacep.2021.12.001_bib195","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.hrthm.2021.08.034","article-title":"Role of subcutaneous implantable loop recorder for the diagnosis of arrhythmias in Brugada syndrome: a United Kingdom single-center experience","volume":"19","author":"Scrocco","year":"2022","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.jacep.2021.12.001_bib196","article-title":"Sex-dependent phenotypic variability of an SCN5A mutation: Brugada syndrome and sick sinus syndrome","volume":"7","author":"Aizawa","year":"2018","journal-title":"J\u00a0Am Heart Assoc"},{"key":"10.1016\/j.jacep.2021.12.001_bib197","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1253\/circj.CJ-16-1295","article-title":"Surface electrocardiogram screening for subcutaneous implantable cardioverter-defibrillators in Japanese patients with and without Brugada syndrome","volume":"81","author":"Kawabata","year":"2017","journal-title":"Circ J"},{"key":"10.1016\/j.jacep.2021.12.001_bib198","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1111\/jce.13315","article-title":"Exercise stress test reveals ineligibility for subcutaneous implantable cardioverter defibrillator in patients with Brugada syndrome","volume":"28","author":"Tachibana","year":"2017","journal-title":"J\u00a0Cardiovasc Electrophysiol"},{"key":"10.1016\/j.jacep.2021.12.001_bib199","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1093\/europace\/eux009","article-title":"High rate of subcutaneous implantable cardioverter-defibrillator sensing screening failure in patients with Brugada syndrome: a comparison with other inherited primary arrhythmia syndromes","volume":"20","author":"Conte","year":"2018","journal-title":"Europace"},{"key":"10.1016\/j.jacep.2021.12.001_bib200","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/j.jacc.2016.05.058","article-title":"Brugada syndrome and the subcutaneous implantable cardioverter-defibrillator","volume":"68","author":"Olde Nordkamp","year":"2016","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacep.2021.12.001_bib201","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.repc.2020.05.013","article-title":"Brugada syndrome: eligibility for subcutaneous implantable cardioverter-defibrillator after exercise stress test","volume":"40","author":"von Hafe","year":"2021","journal-title":"Rev Port Cardiol"},{"key":"10.1016\/j.jacep.2021.12.001_bib202","article-title":"Low prevalence of inappropriate shocks in patients with inherited arrhythmia syndromes with the subcutaneous implantable defibrillator single center experience and long-term follow-up","volume":"6","author":"Rudic","year":"2017","journal-title":"J\u00a0Am Heart Assoc"},{"key":"10.1016\/j.jacep.2021.12.001_bib203","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.hroo.2020.10.002","article-title":"Evaluation of subcutaneous implantable cardioverter-defibrillator performance in patients with ion channelopathies from the EFFORTLESS cohort and comparison with a meta-analysis of transvenous ICD outcomes","volume":"1","author":"Lambiase","year":"2020","journal-title":"Heart Rhythm O2"},{"key":"10.1016\/j.jacep.2021.12.001_bib204","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.jacc.2017.10.082","article-title":"Implantable cardioverter-defibrillators in children and adolescents with Brugada syndrome","volume":"71","author":"Gonzalez Corcia","year":"2018","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacep.2021.12.001_bib205","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1161\/01.CIR.0000088781.99943.95","article-title":"Mapping and ablation of ventricular fibrillation associated with long-QT and Brugada syndromes","volume":"108","author":"Ha\u00efssaguerre","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.jacep.2021.12.001_bib206","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1161\/CIRCEP.115.003220","article-title":"Brugada syndrome phenotype elimination by epicardial substrate ablation","volume":"8","author":"Brugada","year":"2015","journal-title":"Circ Arrhythmia Electrophysiol"},{"key":"10.1016\/j.jacep.2021.12.001_bib207","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1016\/j.hrthm.2018.03.019","article-title":"Ablation strategies for the management of symptomatic Brugada syndrome: a systematic review","volume":"15","author":"Fernandes","year":"2018","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.jacep.2021.12.001_bib208","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCEP.117.005631","article-title":"Efficacy of endocardial ablation of drug-resistant ventricular fibrillation in Brugada syndrome: long-term outcome","volume":"11","author":"Talib","year":"2018","journal-title":"Circ Arrhythmia Electrophysiol"},{"key":"10.1016\/j.jacep.2021.12.001_bib209","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.hlc.2018.09.005","article-title":"Catheter ablation of ventricular fibrillation","volume":"28","author":"Anderson","year":"2019","journal-title":"Heart Lung Circ"},{"key":"10.1016\/j.jacep.2021.12.001_bib210","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCEP.117.005053","article-title":"Electrical substrate elimination in 135 consecutive patients with Brugada syndrome","volume":"10","author":"Pappone","year":"2017","journal-title":"Circ Arrhythmia Electrophysiol"},{"key":"10.1016\/j.jacep.2021.12.001_bib211","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/gim.2015.30","article-title":"Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology","volume":"17","author":"Richards","year":"2015","journal-title":"Genet Med"},{"key":"10.1016\/j.jacep.2021.12.001_bib212","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1111\/jce.13740","article-title":"Systematic re-evaluation of SCN5A variants associated with Brugada syndrome","volume":"30","author":"Denham","year":"2019","journal-title":"J\u00a0Cardiovasc Electrophysiol"},{"key":"10.1016\/j.jacep.2021.12.001_bib213","doi-asserted-by":"crossref","first-page":"2195","DOI":"10.1002\/humu.24128","article-title":"Relationship between sodium channel function and clinical phenotype in SCN5A variants associated with Brugada syndrome","volume":"41","author":"Pearman","year":"2020","journal-title":"Hum Mutat"},{"key":"10.1016\/j.jacep.2021.12.001_bib214","doi-asserted-by":"crossref","first-page":"2878","DOI":"10.1093\/eurheartj\/ehaa383","article-title":"An autoantibody profile detects Brugada syndrome and identifies abnormally expressed myocardial proteins","volume":"41","author":"Chatterjee","year":"2020","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacep.2021.12.001_bib215","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/j.hrthm.2019.11.019","article-title":"New electromechanical substrate abnormalities in high-risk patients with Brugada syndrome","volume":"17","author":"Pappone","year":"2020","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.jacep.2021.12.001_bib216","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1161\/CIRCEP.115.003500","article-title":"Epicardial substrate ablation in Brugada syndrome: time for a randomized trial","volume":"8","author":"Wilde","year":"2015","journal-title":"Circ Arrhythmia Electrophysiol"}],"container-title":["JACC: Clinical Electrophysiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405500X2101080X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405500X2101080X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T07:30:35Z","timestamp":1762500635000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405500X2101080X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3]]},"references-count":216,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,3]]}},"alternative-id":["S2405500X2101080X"],"URL":"https:\/\/doi.org\/10.1016\/j.jacep.2021.12.001","relation":{},"ISSN":["2405-500X"],"issn-type":[{"value":"2405-500X","type":"print"}],"subject":[],"published":{"date-parts":[[2022,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Brugada Syndrome","name":"articletitle","label":"Article Title"},{"value":"JACC: Clinical Electrophysiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacep.2021.12.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 by the American College of Cardiology Foundation. Published by Elsevier.","name":"copyright","label":"Copyright"}]}}